?????????????????? ?????????????????????? ???????????? ?????????? $13.6 ?????????????? ???? 2029 Download PDF Brochure @ https://lnkd.in/d5q9AUEB The report "?????????????????? ?????????????????????? ???????????? ???? ?????????????? (????????????, ????????, ????????????????, ????????????, ???????????????? & ????????????????), ???????????????????? (??????, ??????, ??????, ??????), ???????????????????? (????????????, ????????, ???????????????????? ????????????, ??????, ????????????????????, ??????????????????), ???????????? ???????? (????????????, ??????????) - ???????????? ???????????????? ???? 2029", the global companion diagnostics market is projected to reach USD 13.6 billion by 2029 from USD 7.5 billion in 2024, at a CAGR of 12.6%. #NorthAmerica, particularly the #US. and #Canada, leads the global companion diagnostics market. The region's technological advancement and a high number of product approvals by regulatory authorities, such as the FDA, are driving market growth. For example, in October 2022, F. Hoffmann-La Roche Ltd. received FDA approval for the first companion diagnostic to identify patients with HER2 low metastatic breast cancer. ?????????????????????? ?????????????????? ???????????? ???????? ????????????????: MESO SCALE DIAGNOSTICS, LLC. ACROBiosystems Ventana Medical Systems RareCyte, Inc. Toft Group Executive Search, a ZRG Company Viome Life Sciences HUB Organoids BioChain Institute, Inc. ENDPOINT HEALTH Analytical, Life Science & Diagnostics Association (ALDA) PredxBio Pelago Bioscience AB BioLizard Resolution Bioscience Sayre Therapeutics Rules-Based Medicine a Q2 Solutions Company JJP Biologics Cureline Group - Global Translational CRO Experimental Drug Development Centre (EDDC) Saladax Biomedical Inc. ARC Regulatory Wren Laboratories gMendel HMNC Brain Health BIOPIX DNA TECHNOLOGY S.A. Burning Rock Dx Diagnostech (Pty) Ltd Independent Data Lab Medicover Integrated Clinical Services regenold GmbH CALVIRI TRIGA-S Scientific Solutions York Bioanalytical Solutions NGeneBio Co., Ltd. 4D Path Novodiax Inc Pathology Diagnostics Ltd. CONGEN Biotechnologie GmbH PlexBio Co., Ltd. Shanghai Biotechnology Corporation (SBC)
关于我们
Endpoint Health is a Precision-First therapeutics company dedicated to addressing unmet needs in immune-mediated chronic and acute diseases. We leverage our proprietary artificial intelligence (AI) platform and combine companion diagnostics with therapeutics to develop precision therapies. Our vision is a world in which all patients get the best treatment possible for their unique biology and disease.
- 网站
-
https://endpointhealth.com/
ENDPOINT HEALTH的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Palo Alto，California
- 类型
- 私人持股
- 创立
- 2018